PARATORE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 86
AS - Asia 73
NA - Nord America 72
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 234
Nazione #
US - Stati Uniti d'America 63
IT - Italia 42
JP - Giappone 15
CN - Cina 14
FR - Francia 13
UZ - Uzbekistan 12
HK - Hong Kong 8
CA - Canada 7
IR - Iran 7
GB - Regno Unito 6
IN - India 5
JO - Giordania 5
BD - Bangladesh 3
BE - Belgio 3
DE - Germania 3
DK - Danimarca 3
RU - Federazione Russa 3
AT - Austria 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
MK - Macedonia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
GR - Grecia 1
IL - Israele 1
NL - Olanda 1
PE - Perù 1
PL - Polonia 1
SG - Singapore 1
TR - Turchia 1
Totale 234
Città #
Bukhara 12
Hangzhou 9
Turin 9
Tokyo 7
Santa Cruz 6
Milan 5
Amman 3
Asti 3
Buffalo 3
Copenhagen 3
Fairfield 3
New York 3
Seattle 3
Sylhet 3
Torino 3
Ashburn 2
Barletta 2
Boardman 2
Brussels 2
Central District 2
Chengdu 2
Guatemala City 2
Hürth 2
Kanata 2
London 2
Los Angeles 2
Milton Keynes 2
Monzuno 2
Piemonte 2
Rome 2
San Jose 2
Washington 2
Wilmington 2
Abbiategrasso 1
Amsterdam 1
Annecy 1
Azor 1
Bacoli 1
Bankstown 1
Bari 1
Bridgwater 1
Brussel 1
Cairo 1
Castellaneta 1
Central 1
Chicago 1
Cuttack 1
Fleming Island 1
Fontenay-sous-bois 1
Fujita 1
Gurnee 1
Hamilton 1
Havertown 1
Heidelberg 1
Istanbul 1
Krakow 1
Kumar 1
Lacchiarella 1
Lake Forest 1
Lappeenranta 1
Las Vegas 1
Lexington 1
Lima 1
Marseille 1
Montreal 1
Mumbai 1
Neusiedl am See 1
New Delhi 1
Nishikicho 1
Norfolk 1
Padova 1
Parla 1
Pasadena 1
Philadelphia 1
Reggio Emilia 1
Santa Clara 1
Scranton 1
Sha Tin Wai 1
Skopje 1
Tabriz 1
Thessaloniki 1
Toronto 1
Uppsala 1
Versailles 1
Vienna 1
Woodbridge 1
Wuhan 1
Totale 165
Nome #
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma, file e27ce435-141e-2581-e053-d805fe0acbaa 137
Local for advanced, is this a paradox?, file e27ce434-463e-2581-e053-d805fe0acbaa 39
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review, file e27ce435-747f-2581-e053-d805fe0acbaa 32
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer, file da5de55f-f3c4-4f0c-9ea1-6482648974b4 12
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications, file 51b42c0e-6fd5-4f83-ab92-ed5ce42eafff 9
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020, file c0816eac-2a63-4db7-94e9-38df9877527c 6
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study, file 0b4ab06a-f161-4b4b-8973-9773f73a72e1 2
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review, file e27ce431-dd16-2581-e053-d805fe0acbaa 1
Totale 238
Categoria #
all - tutte 586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202294 0 0 0 0 0 0 6 6 20 21 21 20
2022/2023120 14 7 15 11 10 10 7 20 10 9 7 0
2023/202424 0 0 0 1 1 0 3 4 5 10 0 0
Totale 238